{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:31:29Z","timestamp":1790213489225,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":635,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,3,29]]},"abstract":"<jats:p>We analysed the expression of three drug transporter proteins [p\u2010glycoprotein (PGP), lung resistance\u2010related protein (LRP) and multidrug resistance\u2010associated protein (MRP1)] involved in anthracycline resistance that are frequently overexpressed in poor\u2010risk adult acute non\u2010lymphocytic leukaemia (ANLL), in 23 acute promyelocytic leukaemia (APL) patients at onset managed at a single institution. Cellular daunorubicin accumulation was also evaluated. At onset, no case had PGP or MRP1 expression that exceeded that of non\u2010multidrug\u2010resistant (MDR) cell lines. Only one case showed LRP overexpression. No peculiar MDR features distinguished the seven patients who relapsed from those who maintained complete remission. In the onset vs. first relapse, only one patient showed an increased (threefold) PGP expression at relapse. At second relapse, three out of four patients showed a PGP expression two\u2010 to threefold higher than baseline values. These results are consistent with the view that low PGP, LRP and MRP1 expression and the absence of defects in intracellular drug accumulation may account for the peculiarly high sensitivity of APLs to anthracycline. It does not support the screening of MDR markers in APL patients at onset as predicting factors of early relapse. The results suggest that no significant changes in PGP, LRP or MRP1 expression are likely to occur at first relapse. In contrast, PGP expression is likely to increase later in the patient history as a result of additional chemotherapy courses.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01957.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:23:03Z","timestamp":1047363783000},"page":"703-709","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["P\u2010glycoprotein (PGP), lung resistance\u2010related protein (LRP) and multidrug resistance\u2010associated protein (MRP) expression in acute promyelocytic leukaemia"],"prefix":"10.1111","volume":"108","author":[{"given":"Mariagrazia","family":"Michieli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ermacora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Geromin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Michelutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Masolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00389.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-620"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1182\/blood.V79.12.3267.3267","article-title":"Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug\u2010resistant leukemia cells","volume":"79","author":"Berman E.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.8.632"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.9.9.3808"},{"key":"e_1_2_6_7_2","first-page":"290","article-title":"P\u2010glycoprotein (PGP), and not lung resistance\u2010related protein (LRP), is a negative prognostic factor in secondary leukemias","volume":"83","author":"Damiani D.","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.5.1997.1997"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/10428199709059682","article-title":"P\u2010glycoprotein expression in de novo acute myeloid leukemia","volume":"27","author":"Del Poeta G.","year":"1997","journal-title":"Leukemia and Lymphoma"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05161.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400655"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1182\/blood.V91.5.1508","article-title":"Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia","volume":"91","author":"Filipitis M.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_13_2","first-page":"1236","article-title":"P170 (PGP) expression in leukemic cells after therapeutic exposure to arabinosyl cytosine","volume":"2","author":"Grimaz S.","year":"1998","journal-title":"Advanced Clinical Pathology"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.8.2147.bloodjournal8582147"},{"key":"e_1_2_6_15_2","first-page":"40a","article-title":"Expression of the human major vault protein LRP in haematological malignancy","volume":"86","author":"Hart S.M.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood.V86.5.1717.bloodjournal8651717","article-title":"Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia","volume":"86","author":"Head D.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(96)00053-6"},{"key":"e_1_2_6_18_2","first-page":"1649","article-title":"Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene","volume":"54","author":"Kruth G.D.","year":"1994","journal-title":"Cancer Research"},{"key":"e_1_2_6_19_2","first-page":"35","article-title":"Drug transport variants without P\u2010glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin","volume":"1","author":"Kuiper C.M.","year":"1990","journal-title":"Journal of Cellular Pharmacology"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401361"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.9.3323"},{"key":"e_1_2_6_22_2","first-page":"1086","article-title":"Frequency and clinical significance of the expression of the multidrug resistance proteins, MDR1\/P\u2010glycoprotein, MRP1 and LRP in acute myeloid leukemia. A Southwest Oncology Group study","volume":"94","author":"Leith C.P.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2464.bloodjournal8762464"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.1.55"},{"key":"e_1_2_6_25_2","first-page":"1014","article-title":"Molecular remission in PML\/RAR (\u2010positive acute promyelocytic leukemia by combined all\u2010trans retinoic acid and idarubicin (AIDA) therapy","volume":"90","author":"Mandelli F.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309147379"},{"key":"e_1_2_6_27_2","first-page":"179","article-title":"Screening for multidrug resistance in leukemia: cell reactivity to MRK\u201016 correlates with anthracycline retention and sensitivity of leukemic cells","volume":"18","author":"Michieli M.","year":"1996","journal-title":"Leukemia and Lymphoma"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2020.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01172.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050307"},{"key":"e_1_2_6_31_2","first-page":"968","article-title":"Significantly lower P\u2010glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analysis","volume":"8","author":"Paietta E.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_32_2","first-page":"221","article-title":"The GIMEMA protocol LAP 0389 for the treatment of acute promyelocytic leukemia (APL). Preliminary results","volume":"81","author":"Rotoli B.","year":"1992","journal-title":"British Journal of Haematology"},{"key":"e_1_2_6_33_2","first-page":"1475","article-title":"Overexpression of a Mr 110.000 vesicular protein in non\u2010P\u2010glycoprotein\u2010mediated multidrug resistance","volume":"53","author":"Scheper R.J.","year":"1993","journal-title":"Cancer Research"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.1.186.bloodjournal851186"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05075.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1988.tb01588.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(90)90073-E"},{"key":"e_1_2_6_38_2","first-page":"25","article-title":"The prognostic significance of the expression and function of the multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program","volume":"34","author":"Willman C.L.","year":"1997","journal-title":"Seminars in Hematology"},{"key":"e_1_2_6_39_2","first-page":"1661","article-title":"Expression of multidrug resistance\u2010associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia","volume":"9","author":"Zhou D.C.","year":"1995","journal-title":"Leukemia"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01957.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01957.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01957.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T07:04:00Z","timestamp":1698563040000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01957.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,29]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,3,29]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01957.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01957.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,29]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}